Dental Biomaterials Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Dental Biomaterials Market 

5.1. COVID-19 Landscape: Dental Biomaterials Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Dental Biomaterials Market, By Type

8.1. Dental Biomaterials Market, by Type, 2024-2034

8.1.1. Metallic Biomaterials

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Ceramic Biomaterials

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Polymeric Biomaterials

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Metal-Ceramic Biomaterials

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. Natural Biomaterials

8.1.5.1. Market Revenue and Forecast (2021-2034)

8.1.6. Composites Biomaterials

8.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Dental Biomaterials Market, By Application

9.1. Dental Biomaterials Market, by Application, 2024-2034

9.1.1. Implantology

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Orthodontics

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Prosthodontics

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Dental Biomaterials Market, By End Use Type 

10.1. Dental Biomaterials Market, by End Use Type, 2024-2034

10.1.1. Dental Hospitals and Clinics

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Dental Laboratories

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Dental Academics and Research Institutes

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Dental Product Manufacturers

10.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Dental Biomaterials Market, By Bone Graft Material Type

11.1. Dental Biomaterials Market, by Bone Graft Material Type, 2024-2034

11.1.1. Allograft

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Xenograft

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Synthetic

11.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Dental Biomaterials Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2021-2034)

12.1.2. Market Revenue and Forecast, by Application (2021-2034)

12.1.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.1.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.1.5.2. Market Revenue and Forecast, by Application (2021-2034)

12.1.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.1.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.1.6.2. Market Revenue and Forecast, by Application (2021-2034)

12.1.6.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.1.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.2. Market Revenue and Forecast, by Application (2021-2034)

12.2.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.2.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.5.2. Market Revenue and Forecast, by Application (2021-2034)

12.2.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.2.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.6.2. Market Revenue and Forecast, by Application (2021-2034)

12.2.6.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.2.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.7.2. Market Revenue and Forecast, by Application (2021-2034)

12.2.7.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.2.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.8.2. Market Revenue and Forecast, by Application (2021-2034)

12.2.8.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.2.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.2. Market Revenue and Forecast, by Application (2021-2034)

12.3.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.3.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.5.2. Market Revenue and Forecast, by Application (2021-2034)

12.3.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.3.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.6.2. Market Revenue and Forecast, by Application (2021-2034)

12.3.6.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.3.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.7.2. Market Revenue and Forecast, by Application (2021-2034)

12.3.7.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.3.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.8.2. Market Revenue and Forecast, by Application (2021-2034)

12.3.8.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.3.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.2. Market Revenue and Forecast, by Application (2021-2034)

12.4.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.4.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.5.2. Market Revenue and Forecast, by Application (2021-2034)

12.4.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.4.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.6.2. Market Revenue and Forecast, by Application (2021-2034)

12.4.6.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.4.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.7.2. Market Revenue and Forecast, by Application (2021-2034)

12.4.7.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.4.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.8.2. Market Revenue and Forecast, by Application (2021-2034)

12.4.8.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.4.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.5.2. Market Revenue and Forecast, by Application (2021-2034)

12.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.5.5.2. Market Revenue and Forecast, by Application (2021-2034)

12.5.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.5.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.5.6.2. Market Revenue and Forecast, by Application (2021-2034)

12.5.6.3. Market Revenue and Forecast, by End Use Type (2021-2034)

12.5.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)

Chapter 13. Company Profiles

13.1. 3M Company

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Bego Medical GmbH

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Carpenter Technology Corporation

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Danaher Corporation

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Datum Dental Ltd.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. GC Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Henry Schein Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. IvoclarVivadent AG

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Keystone Dental Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Medtronic PLC

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms